A Pharmacokinetic Study of SHR8554 Injection in the Population With Renal Insufficiency and Healthy Participants

NCT07189962 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Postoperative Pain

Interventions

DRUG: SHR8554 Injection

Sponsor

Jiangsu HengRui Medicine Co., Ltd.